Zobrazeno 1 - 10
of 47
pro vyhledávání: '"D D Sviridov"'
Autor:
Michael Bukrinsky, Nigora Mukhamedova, Alexander A. Makarov, D D Sviridov, Alexei A. Adzhubei
Publikováno v:
AIDS (London, England)
Combination antiretroviral therapy has dramatically changed the outcome of HIV infection, turning it from a death sentence to a manageable chronic disease. However, comorbidities accompanying HIV infection, such as metabolic and cardio-vascular disea
Autor:
Tatiana Pushkarsky, D D Sviridov, Sara Karandish, Michael Bukrinsky, Larisa Dubrovsky, Michael L. Fitzgerald, Dominic S. Raj, Ali Ramezani
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 354:376-383
Previous studies demonstrated that liver X receptor (LXR) agonists inhibit human immunodeficiency virus (HIV) replication by upregulating cholesterol transporter ATP-binding cassette A1 (ABCA1), suppressing HIV production, and reducing infectivity of
Publikováno v:
Endocrinology. 136:3707-3713
Glucocorticoids have been reported to protect against atherosclerosis and have been used clinically as protective therapy for restenosis after balloon angioplasty. Recently, Lp(a) lipoprotein [Lp(a)] levels have been suggested to be an independent ri
Autor:
J. L. Nano, V.S. Repin, P. Rompal, Wei Huang, E. V. Zaitseva, E. G. Frolova, T. G. Vishnyakova, A. V. Bocharov, D. D. Sviridov
Publikováno v:
Bulletin of Experimental Biology and Medicine. 117:52-55
It is shown that glucocorticoids play a key regulatory role directed toward the maintenance of an optimal level of binding and internalization of HDL3 in hepatocytes. Their stimulatory effect on the expression of HDL receptors proves to be independen
Autor:
Steven J. Demosky, V N Smirnov, I G Safonova, G E Tennyson, Jeffrey M. Hoeg, V S Repin, D Bojanovski, D D Sviridov, M S Meng, M. B. Kuberger
Publikováno v:
Journal of Lipid Research, Vol 31, Iss 10, Pp 1761-1769 (1990)
Apolipoprotein B (apoB), an apolipoprotein associated with very low density lipoproteins and the atherogenic low density lipoproteins (LDL), directs the metabolism of lipoprotein particles in plasma by interacting with the LDL receptor. Utilizing hum
Autor:
H. Bryan Brewer, Thomas L. Eggerman, Irina G. Safonova, D D Sviridov, Jeffrey M. Hoeg, Stephen J. Demosky
Publikováno v:
Digestion. 67(1-2)
Low-density lipoprotein receptor (LDL-R) was found to be expressed in human small intestine epithelial cells, enterocytes. The relative abundance of LDL-R mRNA and protein was compared with that of apolipoproteins A-I (apoA-I) and B (apoB) in enteroc
Autor:
Khuang Véĭ, T G, Vishniakova, A V, Bocharov, E V, Zaĭtseva, E G, Frolova, D D, Sviridov, V S, Repin, Zh L, Nano, P, Rompal'
Publikováno v:
Biulleten' eksperimental'noi biologii i meditsiny. 117(1)
Publikováno v:
Klinicheskaia laboratornaia diagnostika. (1)
Publikováno v:
Journal of lipid research. 34(2)
A new model to study cholesterol uptake in the human intestine in vitro is described. Human small intestine organ cultures were incubated with mixed micelles containing bile acid, phospholipid, and cholesterol or its nonabsorbable analogue, sitostero
Publikováno v:
Journal of Lipid Research, Vol 31, Iss 10, Pp 1821-1830 (1990)
Scopus-Elsevier
Scopus-Elsevier
The effect of two inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, lovastatin and monacolin L, and an inhibitor of acyl coenzyme A:cholesterol acyltransferase (ACAT), Sandoz compound 58-035, on the interaction of 125I-labeled